Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sai Life Sciences

Explore full profile

Delivers advanced Discovery, Contract Development and Manufacturing Solutions

IndiaFounded 1999Biotech & Life Sciences
Valuation $2.5–5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 2–5k Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Sai Life Sciences and the history behind them.

About Sai Life Sciences

Sai Life Sciences is a global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides end-to-end solutions to innovator biotech and pharma companies. The company operates in India and internationally, offering services that span the entire drug discovery and development process, from Hit to IND (Investigational New Drug). As a full-service CRO-CDMO, Sai Life Sciences partners with its clients to accelerate their journey in bringing new small molecule drugs to market.

The company's services include chemistry, manufacturing, and controls (CMC), discovery biology, and in-vivo pharmacokinetics (PK) services. With a strong focus on partnership, Sai Life Sciences has established itself as a trusted partner for over 200 companies, delivering a portfolio of molecules at various stages, from discovery to commercial launch. The company has demonstrated consistent growth, positioning itself as one of the fastest-growing CRDMOs among its Indian peers.

In addition to its core business, Sai Life Sciences is committed to sustainability and has joined the Science Based Targets initiative to help combat climate change. This reflects the company's dedication to responsible corporate citizenship alongside its scientific and commercial objectives.

Source: Dealroom company data

At a glance

Founded
1999
Headquarters
India
Sector
Biotech & Life Sciences

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later4 investors entered at this stage

  • MPM BioImpact
  • Tata Capital
  • TPG
  • Abu Dhabi Investment Authority
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
15 countries with
team presence
🇮🇳 India95.2%
🇬🇧 United Kingdom2.3%
🇺🇸 United States1.3%
🇳🇱 Netherlands0.1%
🇨🇦 Canada0.1%
Top 5 of 15 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sai Life Sciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sai Life Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.